Indication
Neonatal Abstinence Syndrome
8 clinical trials
6 products
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-studyStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
BuprenorphineClinical trial
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine FormulationsStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): Infant Neurodevelopmental Outcomes (INO) Sub-studyStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young BrainStatus: Active (not recruiting), Estimated PCD: 2025-03-01
Product
ClonidineProduct
MorphineClinical trial
Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant WomenStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Understanding the microRNA Response to Opioid Withdrawal and Their Uses as Potential Biomarkers for Neonatal Abstinence SyndromeStatus: Recruiting, Estimated PCD: 2024-10-10
Product
Buccal swab salivaClinical trial
Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence SyndromeStatus: Terminated, Estimated PCD: 2019-03-26
Product
MethadoneClinical trial
Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence SyndromeStatus: Completed, Estimated PCD: 2018-06-01